Comparison of three treatment regimens with liposomal amphotericin B (AmBisome®) for visceral leishmaniasis in India: A randomized dose-finding study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 3, 1996, Pages 319-322

  Thakur, C P ^a,d   Pandey, A K ^a   Sinha, G P ^a   Roy, Sobhic ^a   Behbehani, K ^b   Olliaro, P ^c  

^a PATNA MEDICAL COLLEGE AND HOSPITAL   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c WORLD BANK   (United States)

^d NONE   (India)

Author keywords

AmBisome ; Leishmania donovani; Leishmaniasis; Liposomal amphotericin B; Visceral

Indexed keywords

ALBUMIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; HEMOGLOBIN; LIPOSOME;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; INDIA; LEUKOCYTE COUNT; MALE; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

EID: 0030006792     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90271-0     Document Type: Article

References (16)

1. Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barrai, A., Carvalho, J. S., Barral-Netto, M., Brandley, M., Silva, L., Bina, J. C., Teixera, R., Falcoff, R., Rocha, H., Ho, J. L. & Johnson, W. D. (1990). Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, 322, 16-17.
2. Berman, J. D., Hanson, W. L., Chapman, W. K., Alving, C. R. & Lopez-Berestein, G. (1986). Antileishmanial activity of liposome encapsulated amphotericin B in hamsters and monkeys. Antimicrobial Agents and Chemotherapy, 30, 847-851.
3. Chulay, J. D., Bhatt, S. M., Mugai, R., Ho, G., Gachihi, J., Were, J. B. O., Chunge, C. & Bryceson, A. D. M. (1983). A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Journal of Infectious Diseases, 148, 248-255.
4. Davidson, R. N., Croft, S. L., Scott, A. G., Maini, M., Moody, A. H. & Bryceson, A. D. M. (1991). Liposomal amphotericin B in drug resistant visceral leishmaniasis. Lancet, 337, 1061-1062.
5. Davidson, R. N., Di Martino, L., Gradoni, L., Giacchino, R., Russo, R., Gaeta, G. B., Pempinello, R., Scott, S., Raimondi, F., Cascio, A., Prestilleo, T., Caldeira, L., Wilkinson, R. J. & Bryceson, A. D. M. (1994). Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multicentre trial. Quarterly Journal of Medicine, 87, 75-81.
6. Dietze, R., Milan, E. P., Berman, J. D., Grogl, M., Falqueto, A., Feitosa, T. F., Luz, K. G., Suassuna, F. A. B., Marinho, L. A. C. & Ksionski, G. (1993). Treatment of Brazilian kala-azar with a short course of Amphocil (amphotericin B cholesterol dispersion). Clinical Infectious Diseases, 6, 981-986.
7. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Review of Infectious Diseases, 12, 308-329.
8. Gradoni, L., Bryceson, A. & Desjeux, P. (1995). Treatment of Mediterranean visceral leishmaniasis. Bulletin of the World Health Organization, 73, 191-197.
9. Kan, V. L., Bennet, J. E., Amantea, M. A., Smolsksis, M. C., McManus, E., Grasela, D. M. & Sherman, J. W. (1991). Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in healthy male volunteers. Journal of Infectious Diseases, 164, 418-421.
10. Levine, S. J., Walsh, T. J., Martinez, A., Eichacker, P. O., Lopez-Berestein, G. & Natanson, C. (1991). Cardiopulmonary toxicity after liposomal amphotericin B infusion. Annals of Internal Medicine, 114, 664-666.
11. Mishra, M., Singh, M. P., Choudhary, D., Singh, V. P. & Khan, A. B. (1991). Amphotericin B for second line treatment of Indian kala-azar. Lancet, 337, 926.
12. Thakur, C. P. (1993). Diminishing effectiveness of currently used drugs in treatment of kala-azar and amphotericin B in antimony and pentamidine resistant kala-azar. In: Current Trends in Leishmania Research, Bhaduri, A. N., Basu, M. K., Sen, A. K. & Kumar, S. (editors). New Delhi: Council of Scientific and Industrial Research, pp. 254-269.
13. Thakur, C. P. (1995). Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration. National Medical Journal of India, 8, 13-14.
14. Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N. & Pandey, A. K. (1988). Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. British Medical Journal, 196, 157-161.
15. Thakur, C. P., Kumar, M. & Pandey, A. K. (1991). Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. American Journal of Tropical Medicine and Hygiene, 45, 435-441.
16. Thakur, C. P., Sinha, G. P., Pande, A. K., Barat, D. & Sinha, P. K. (1993). Amphotericin B in resistant kala-azar in Bihar. National Medical Journal of India, 6, 57-60.